N/A N=112 Randomized Supportive Care

CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)

Human Immunodeficiency Virus

Bottom Line

View on ClinicalTrials.gov: NCT01721226 ↗

Enrolled (actual)

112

Serious AEs

0.0%

Results posted

Feb 2017

Primary outcome: Primary: Plasma Viral Load Suppression — 26; 23; 23; 24 participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Intervention Arm (computer-based CARE+ Corrections tool) (Device); Educational video on opiate overdose prevention (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: George Washington University
Primary completion: May 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Plasma Viral Load Suppression	26; 23; 23; 24	—
SECONDARY Linkage to Community Care	45; 47; 6; 5	—

Summary

The purpose of this study is to determine whether an intervention (CARE+ Corrections) delivered to HIV-infected detainees within the DC Department of Corrections (DOC) and recently -released ex-detainees in the community can improve linkage to community HIV care and adherence to HIV medications after release, and ultimately achieve or maintain HIV viral suppression following community re-entry.

Eligibility Criteria

Inclusion Criteria

Currently detained in jail or released from the jail/prison 6 months ago or less
18 years of age or older
English speaking
Able to provide informed consent for research participation
Anticipated release from the DOC to the community (or living in the community if recently released ex-detainee)
Confirmed to be HIV-infected by self-report
Live in metropolitan Washington, DC area
Able to read at 8th grade level as assessed by brief literacy screen

Exclusion Criteria

Expected release to restricted setting (or currently living in a restricted setting if recruited in the community), including residential drug treatment, sober house, half-way house, or similar

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01721226). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.